SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that states can regulate or restrict sports-event contracts dealt a setback to Kalshi-style prediction markets, easing a major competitive and regulatory concern for DraftKings and prompting a sharp but contested rebound. Traders remain divided over whether the ruling will materially improve DraftKings long-term margins and market share, given possible further appeals and continued competition from prediction platforms.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of FAYUVI, the first treatment for Sanfilippo syndrome type A, is driving attention, along with the accompanying Priority Review Voucher and planned commercial launch. Traders are broadly bullish on the approval and potential short covering, though some question the muted share-price reaction, limited patient population, and commercialization and cash-burn risks.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

The Federal Reserves interest-rate hike is driving attention, with traders debating whether it was already priced into SOFI and whether higher rates will benefit bank spreads or pressure lending demand, funding costs, and credit. The community is split between buyers who view the move as a priced-in opportunity and skeptics focused on continued macro pressure and the stocks weak performance.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

A sharp post-earnings selloff and valuation reset have driven attention, with traders citing the high multiple, consumer and restaurant-sector pressures, and uncertainty around the Salad and Go site deal and possible dilution. Bulls argue that strong growth, store expansion, and continued customer traffic make the decline an opportunity, while bears expect further downside as growth and margins face pressure.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation is building around Helus Pharmas pivotal Phase 3 HLP003 APPROACH readout, with traders citing ahead-of-schedule enrollment, encouraging Phase 2 results, and recent leadership and insider-buying activity as signs of confidence. The bullish reaction is tempered by debate over whether expectations are already priced in and whether future financing could dilute shareholders.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid repeated staged lockup expirations and insider share sales, which traders say are creating persistent supply and volatility. Bulls continue to point to the companys AI-inference demand, including cloud and data-center partnerships, as a counterpoint to the near-term selling pressure.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp NEAR rally has drawn attention amid speculation that Arthur Hayes sold NEAR alongside other tokens, with traders noting the tokens outperformance afterward. The community is split between bullish views tied to NEARs AI-agent, chain-abstraction and Intents narrative and warnings that the move may be a technical pump or liquidity trap.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs weaker-than-expected quarterly results and reduced outlook, driven largely by BetterHelps difficult shift from cash-pay to insurance and limited therapist capacity, are dominating attention. Traders are divided between viewing the revenue pressure as a temporary transition bottleneck and seeing it as evidence of poor execution and weak management credibility.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Management commentary on clearer Medicare reimbursement prospects for Tempuss tissue-scanning and liquid-biopsy tests is driving attention, reinforcing the commercial outlook for its diagnostics business. Traders are broadly bullish and discussing breakout and short-squeeze potential, while others cite insider selling, elevated valuation, and pullback risk.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Anticipation of BlackBerrys September 24 quarterly report is driving attention, with traders positioning for stronger guidance and possible Alloy Kore updates. Bullish discussion also highlights QNXs Sift integration and broader physical-AI opportunity, while skeptics question revenue growth, management execution, and whether earnings-driven gains can hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SNAP Stock Rises Overnight After Specs AI Tool Unveiling — Retail Gets More Bullish

Snaps launch of its Specs augmented-reality glasses, Specs Intelligence AI assistant, and related enterprise partnerships has become the dominant catalyst. Traders are split between viewing the technology as a potentially transformative computing platform and criticizing the products high price, uncertain demand, management credibility, and recurring sell-the-news price action.

The price move is being attributed to the company's presentation of its new Specs augmented reality glasses and the unveiling of its Specs Intelligence AI assistant. Investors are focusing on the product's enterprise-focused capabilities and key partnerships with companies such as Nvidia, Amazon Web Services, and Salesforce.

Snap (SNAP) Stock Sinks As Market Gains: What You Should Know

Snap (SNAP) closed at $5.65 in the latest trading session, marking a -1.22% move from the prior day.

Here's Why Snap (SNAP) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Nasdaq, S&P 500 Futures Rebound After Fed Rate Hike: NVDA, NBIS, SNAP, SPCX, BE, GNRC Stocks In Focus

Equity

Retail sentiment on SPY and QQQ remained ‘bearish’, even as futures recovered.


Dow, S&P 500, Nasdaq Futures Edge Higher After Fed Delivers Rate Hike: SPCX, CADL, SNAP, FLNC Stocks In Focus

The Federal Reserve On Wednesday hiked benchmark interest rates by 25 bps to a target range of 3.75% to 4.00%, in line with market expectations. 

Snap is betting its AR hardware can evolve beyond photography into a broader computing platform.


Snap Inc. Introduces SPECS Intelligence, an Anticipatory AI Service

Snap Inc. (NYSE: SNAP) today introduced SPECS Intelligence, a new anticipatory AI service designed to work across iPhone, Mac, and SPECS augmented reality (AR) glasses, helping you manage what needs attention today while making progress towards your longer-term goals. This press release features...

SPECS Make Computing More Human with New Experiences, Partnerships, and SPECS Intelligence

Snap Inc. (NYSE: SNAP) today announced new experiences, services and partnerships for SPECS, a new kind of computer built into a pair of augmented reality (AR) glasses. These innovations and partnerships advance Snaps vision to make computing more human, and include new AR experiences; SPECS...

Why Is Snap Stock Surging on Tuesday?

Snap Inc. (NYSE: SNAP) stock rises Tuesday ahead of its Wednesday hardware showcase featuring the new "Specs" augmented reality glasses in Los Angeles.read more...

PINS Rides on Strength in Ad Business: Can Momentum Sustain?

Pinterest is gaining advertiser demand as AI tools improve campaign performance, but fierce competition and a 45.7% stock decline cloud its momentum.

Stocktwits Tech Watch: Anthropic's AI Slowdown Row, Salesforce And Snap Events, And A Central Bank Rate Call In Focus This Week

Markets brace for a packed week of AI, tech and macro catalysts.


This account has been verified as an official SNAP representative.

Verified Account

Nicole Petrosino

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Extremely Bullish Sentiment

More bullish - Specs changes the story

Same - still neutral / wait and see

More bearish - pricey hardware, cash burn worries

Already bearish - staying short / avoiding

$2,195 Specs are here. $SNAP says it's the future. Are you a believer or is this just going to burn cash and investors.

Snap ($SNAP) just unveiled its $2,195 Specs AR glasses at AWE. After the announcement, where are you on the stock? 
 
Drop a comment if you own the stock.

Stocktwits

Snap Inc

) just unveiled its $2,195 Specs AR glasses at AWE. After the announcement, where are you on the stock? 
 
Drop a comment if you own the stock.

Stocktwits Polls

Investors are closely watching the market impact of the new enterprise-focused AR smart glasses and integrated AI platform.

Traders are intensely focused on the struggle to break through and hold the key $6.00 psychological price resistance level.

Optimism surrounds new enterprise-level partnerships with major tech giants including Nvidia, AWS, and Salesforce.

Shareholders are voicing extreme frustration regarding consistent insider selling and overall lack of faith in executive leadership.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.01	--	--	N/A
Q2 '26	-$0.12	-$0.10	18.32%	BEAT
Q1 '26	-$0.07	-$0.05	25.20%	BEAT
Q4 '25	-$0.03	$0.03	196.95%	BEAT
Q3 '25	-$0.12	-$0.06	50.75%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNAP Earnings

Upcoming Earnings: Q3 '26

Historical Earnings